| Autor: |
Luo BQ; The Respiratory Centre, the Second Affiliated Hospital of Xiamen Medical College, Xiamen 361021, China., Ke MY; The Respiratory Centre, the Second Affiliated Hospital of Xiamen Medical College, Xiamen 361021, China., Zeng JL; The Respiratory Centre, the Second Affiliated Hospital of Xiamen Medical College, Xiamen 361021, China., Huang R; The Respiratory Centre, the Second Affiliated Hospital of Xiamen Medical College, Xiamen 361021, China., Lin LC; The Respiratory Centre, the Second Affiliated Hospital of Xiamen Medical College, Xiamen 361021, China., Wu XM; The Respiratory Centre, the Second Affiliated Hospital of Xiamen Medical College, Xiamen 361021, China., Yong YZ; The Respiratory Centre, the Second Affiliated Hospital of Xiamen Medical College, Xiamen 361021, China. |
| Jazyk: |
čínština |
| Zdroj: |
Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases [Zhonghua Jie He He Hu Xi Za Zhi] 2020 Jul 12; Vol. 43 (7), pp. 571-576. |
| DOI: |
10.3760/cma.j.cn112147-20191024-00710 |
| Abstrakt: |
Objective: To explore the efficacy and safety of the covered airway stent loaded with (125)I seeds for the treatment of tracheal adenoid cystic carcinoma (TACC). Methods: We retrospectively reviewed the clinical data from 8 patients with TACC who had received placement of the covered stent loaded with (125)I seeds between December 2014 and July 2017 in the endoscopic center of the Second Affiliated Hospital of Xiamen Medical College. We compared the difference in the dyspnea index, the diameter of the airway lumen, and the lesion surrounding the airway wall before and after treatment. The complications were also recorded during follow-up. Results: Eight patients underwent successful placement of a total of 11 radioactive stents (2 straight-type stents, 2 L-shape stents, and 7 Y-shape stents, all loaded a total of 243 radioactive particles). Displacement of stents took place within 2 weeks in 2 patients, who were managed with re-stenting and fixation. No further displacement occurred during follow-up. The median time to stent removal was 2.9(interquartile range: 2.3,3.0) months. After stent placement, the dyspnea index was significantly decreased compared with pre-treatment level (mean: 0.1 vs. 3.4, t= 8.881, P< 0.001). Bronchoscopic re-assessment showed that the residual tumor within the airway was detected in only one patient and that the tumor completely disappeared in the remaining 7 patients. Treatment with stents loaded with radioactive particles yielded smooth and pale airway mucosa with formation of partial scar formation. Chest computed tomography re-assessment demonstrated significantly larger luminal diameter than that before treatment (mean: 13.1 mm vs. 3.3 mm, t= -7.839, P< 0.001). The airway wall thickness was notably reduced after treatment (mean: 4.3 mm vs. 14.4 mm, t= 7.620, P< 0.001). The lesions surrounding the airway wall completely disappeared in 7 patients and decreased for more than 50% in a single patient. The median duration of follow-up was 28.0(interquartile range: 24.8,31.5) months. Recurrence of tumor was documented in a single case within 2 years. Six patients did not experience recurrence within the 2-year follow-up period. No death or severe complications were recorded during follow-up. Conclusion: The (125)I radioactive stent is effective for dilating the stenotic airway and ameliorating the symptoms, and thus might be an effective and safe method for the treatment of TACC. Further studies that explore the efficacy of stents loaded with (125)I particles are needed. |
| Databáze: |
MEDLINE |
| Externí odkaz: |
|
